MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$233,627K
Cash and cash
equivalents
$183,641K
Accounts receivable, net
$85,057K
Prepaid expenses
$13,473K
Inventory
$4,372K
Other receivables
$2,052K
Restricted cash
$560K
Total current assets
$522,782K
Property and equipment,
net
$11,665K
Operating lease
right-of-use assets
$10,080K
Intangible assets, net
$7,366K
Long-term investments
$3,870K
Inventory, non-current
$2,532K
Restricted cash,
non-current
$2,002K
Other assets
$1,861K
Total assets
$562,158K
Total liabilities and
stockholders equity
$562,158K
Total stockholders
equity
$343,426K
Total liabilities
$218,732K
Accumulated deficit
-$426,628K
Additional paid-in capital
$769,667K
Total current
liabilities
$135,695K
Long-term debt, net
$72,438K
Other long-term
liabilities
$10,599K
Accumulated other
comprehensive income (loss)
$381K
Common stock, 0.0001
par value...
$6K
Other accrued
liabilities
$101,529K
Accrued payroll and
benefits
$17,779K
Accounts payable
$16,387K
Back
Back
Balance Sheet
source: myfinsight.com
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)